Finance

Lists
4521:TYO
Kaken Pharmaceutical Co Ltd
JP¥ 3,775.00
-1.56%
(-60.00) 1D
10-р сарын 2, 15:30:00 (GMT+9)  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4521...
Open
JP¥ 3,810
High
JP¥ 3,820
Low
JP¥ 3,775
Mkt. cap
166.63Т
Avg. vol.
113.38 мян
Volume
122.60 мян
Dividend
5.03%
Quarterly dividend
JP¥ 47
Ex-dividend date
2026 оны 9-р сарын 29
P/E ratio
13.86
52-wk high
JP¥ 4,445
52-wk low
JP¥ 3,540
EPS
JP¥ 272
Shares outstanding
39.72 сая
No. of employees
1 мян.
Open
JP¥ 3,810
High
JP¥ 3,820
Low
JP¥ 3,775
Mkt. cap
166.63Т
Avg. vol.
113.38 мян
Volume
122.60 мян
Dividend
5.03%
Quarterly dividend
JP¥ 47
Ex-dividend date
2026 оны 9-р сарын 29
P/E ratio
13.86
52-wk high
JP¥ 4,445
52-wk low
JP¥ 3,540
EPS
JP¥ 272
Shares outstanding
39.72 сая
No. of employees
1 мян.
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
40 минутын өмнө
What Had To Hold Up For OptimizeRx (OPRX) And What Broke First?
Business Insider
Business Insider
·
16 цагийн өмнө
The NYSE's Most Famous Floor Trader Says AI Can't Take His Job
The Motley Fool
The Motley Fool
·
3 цагийн өмнө
History Says Coca-Cola Stock Holds Up When the S&P 500 Falls
About Kaken Pharmaceutical Co Ltd
CEO-
Employees1.11 мян
Founded1917
Headquarters-
SectorPharmaceutical industry
Last report
2026 оны 8-р сарын 7
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
30.16 тэрбум / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
20.49 тэрбум
18.26 тэрбум
19.25 тэрбум
30.16 тэрбум
Cost of goods sold
8.78 тэрбум
9.01 тэрбум
10.09 тэрбум
9.18 тэрбум
Cost of revenue
8.78 тэрбум
9.01 тэрбум
10.09 тэрбум
9.18 тэрбум
Research and development expenses
6.29 тэрбум
3.97 тэрбум
4.94 тэрбум
4.60 тэрбум
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.23 тэрбум
4.92 тэрбум
4.92 тэрбум
5.47 тэрбум
Operating expense
11.52 тэрбум
8.90 тэрбум
10.62 тэрбум
10.07 тэрбум
Total operating expenses
20.30 тэрбум
17.91 тэрбум
20.71 тэрбум
19.25 тэрбум
Operating income
187.00 сая
354.00 сая
-1.46 тэрбум
10.90 тэрбум
Other non operating income
-27.00 сая
34.00 сая
43.00 сая
8.00 сая
EBT including unusual items
988.00 сая
588.00 сая
328.00 сая
11.24 тэрбум
EBT excluding unusual items
184.00 сая
598.00 сая
-1.41 тэрбум
11.26 тэрбум
Income tax expense
267.00 сая
182.00 сая
-418.00 сая
2.80 тэрбум
Effective tax rate
27.02%
-
-127.44%
24.93%
Other operating expenses
-
-
-
-
Net income
721.00 сая
406.00 сая
746.00 сая
8.44 тэрбум
Net profit margin
3.52%
-
3.87%
27.99%
Earnings per share
-
-
-
-
Interest and investment income
78.00 сая
324.00 сая
91.00 сая
393.00 сая
Interest expense
-11.00 сая
-11.00 сая
-13.00 сая
-14.00 сая
Net interest expenses
67.00 сая
313.00 сая
78.00 сая
379.00 сая
Depreciation and amortization charges
-
-
752.00 сая
-
EBITDA
922.00 сая
992.50 сая
-624.75 сая
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс